dangers of glp-1 The promise and peril agonists: What we do (and don't) know as of August 2024 The Dangers of GLP-1 Agonists

GLP-1 receptor agonists have shown strong efficacy in promoting weight loss and improving glycemic control, making them a preferred choice for patients with obesity, type 2 diabetes, and cardiovascular risk factors

10.3389/fendo.2019.00492 Front

Treatment protocols generally recommend: Initial phase: Twice-weekly injections for optimal results Maintenance phase: Monthly injections for sustained benefits Individual adjustments based on patient response Is a MIC B12 shot better than a pill

With such broad benefits, tirzepatide weight loss results often exceed those seen with other medications

Do not use if governed by any body that prohibits hormone use

This scenario supports the hypothesis that LAB which if at all, synthesize glutathione are able to do so by the glutathione biosynthesis bifunctional fusion protein